Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition
Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal ...
Thursday, May 1, 2025
Tag: disease
Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease
Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the ...
Novartis Nabs First FDA Nod in Rare Kidney Disease, But Apellis Pharma Is on Its Heels
An ultra-rare kidney disease that can become life-threatening now has its first FDA-approved therapy. The affirmative regulatory decision is the ...
Gene Hackman died of heart disease, his wife of hantavirus, say authorities
Authorities revealed Friday that actor Gene Hackman died of heart disease and showed severe signs of Alzheimer’s disease a full ...
Transforming Our Collective Approach to Alzheimer’s Disease Care Begins with Early and Accurate Diagnosis
Over the last two years, we’ve seen some of the most impactful scientific advancements in Alzheimer’s disease diagnostics and treatment ...
8 in 10 women believe their intuition is a sixth sense—but most still ignore it, study finds
Eight in 10 women feel like they have a sixth sense (77%), according to new research. A survey of 2,000 ...
Sanofi Drug for Rare Blood Disease Is Heading to Recordati for $825M
Sanofi’s Enjaymo, the only approved drug therapy for a rare and debilitating blood disorder, is being acquired by Recordati in ...
Got COVID? Here are the new 2024 isolation guidelines
Two lines appear on the test card, 15 minutes after you’ve swabbed the depths of your nostrils and swirled the ...
Readout: CDC and OASH’s Office of Science and Medicine Host Roundtable on Vector-Borne Disease National Strategy
As part of ongoing public engagement on vector-borne diseases, on Thursday, May 23, 2024, the Centers for Disease Control and ...
Insmed’s Trial Results Pave Way for FDA Filing in a Lung Disease With No Approved Therapies
An Insmed drug developed for a serious chronic lung disorder with no FDA-approved therapies handily beat a placebo in a ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.